1. Home
  2. LSBPW vs THS Comparison

LSBPW vs THS Comparison

Compare LSBPW & THS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSBPW
  • THS
  • Stock Information
  • Founded
  • LSBPW N/A
  • THS 2021
  • Country
  • LSBPW China
  • THS United States
  • Employees
  • LSBPW 758
  • THS N/A
  • Industry
  • LSBPW Biotechnology: Pharmaceutical Preparations
  • THS Packaged Foods
  • Sector
  • LSBPW Health Care
  • THS Consumer Staples
  • Exchange
  • LSBPW Nasdaq
  • THS Nasdaq
  • Market Cap
  • LSBPW N/A
  • THS N/A
  • IPO Year
  • LSBPW N/A
  • THS N/A
  • Fundamental
  • Price
  • LSBPW $0.05
  • THS $33.63
  • Analyst Decision
  • LSBPW
  • THS Hold
  • Analyst Count
  • LSBPW 0
  • THS 5
  • Target Price
  • LSBPW N/A
  • THS $34.20
  • AVG Volume (30 Days)
  • LSBPW N/A
  • THS 623.4K
  • Earning Date
  • LSBPW N/A
  • THS 02-14-2025
  • Dividend Yield
  • LSBPW N/A
  • THS N/A
  • EPS Growth
  • LSBPW N/A
  • THS N/A
  • EPS
  • LSBPW N/A
  • THS N/A
  • Revenue
  • LSBPW N/A
  • THS $3,359,100,000.00
  • Revenue This Year
  • LSBPW N/A
  • THS N/A
  • Revenue Next Year
  • LSBPW N/A
  • THS $1.29
  • P/E Ratio
  • LSBPW N/A
  • THS N/A
  • Revenue Growth
  • LSBPW N/A
  • THS N/A
  • 52 Week Low
  • LSBPW N/A
  • THS $28.04
  • 52 Week High
  • LSBPW N/A
  • THS $43.84
  • Technical
  • Relative Strength Index (RSI)
  • LSBPW N/A
  • THS 43.91
  • Support Level
  • LSBPW N/A
  • THS $32.28
  • Resistance Level
  • LSBPW N/A
  • THS $34.81
  • Average True Range (ATR)
  • LSBPW 0.00
  • THS 0.84
  • MACD
  • LSBPW 0.00
  • THS 0.09
  • Stochastic Oscillator
  • LSBPW 0.00
  • THS 49.27

About LSBPW LakeShore Biopharma Co. Ltd

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

Share on Social Networks: